About SKYRIZI
SKYRIZI is a company based in Chicago (United States) founded in 2018. It operates as a B2B. SKYRIZI offers products and services including SKYRIZI. SKYRIZI operates in a competitive market with competitors including Mediately, Iodine, RxWiki, Tuune and Alibaba Health, among others.
- Headquarter Chicago, United States
- SectorsHealthcare
- Website skyrizihcp.com
- Legal Name Abbvie Inc.
Products & Services of SKYRIZI
SKYRIZI offers a comprehensive portfolio of products and services, including SKYRIZI.
Medication for treating plaque psoriasis and related conditions.
Competitors of SKYRIZI
SKYRIZI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mediately, Iodine, RxWiki, Tuune and Alibaba Health, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mediately.co | 2011 | Ljubljana, Slovenia | $8.73M | – | Online information portal on medicines | |
| iodine.com | 2013 | San Francisco, United States | $2.5M | 714 | Information platform for healthcare products and conditions | |
| rxwiki.com | 2010 | Austin, United States | $5.75M | 76 | Digital medication encyclopaedia | |
| tuune.com | 2018 | London, United Kingdom | $4.75M | 6 | Personalized contraceptive pills are provided via an online platform. | |
| alihealth.cn | 1998 | Beijing, China | – | 2 | Online platform for pharmacy, consultations, and appointments is operated. | |
| myrxprofile.com | 2014 | Colts Neck, United States | – | – | App for tracking prescriptions, providing drug alerts, and managing medication safety. | |
| obino.in | 2012 | Mumbai, India | $680,275 | 18 | Mobile app guide for weight-loss advice |
Detailed competitors of SKYRIZI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SKYRIZI
Websites that share an audience with SKYRIZI (skyrizihcp.com).
Websites whose visitors overlap most with SKYRIZI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| xcenda.com | 60% | – | – | View details | |
| cslbehring.com | 60% | 78.2K | #544,483 | View details | |
| eversana.com | 55% | 38.7K | #636,017 | View details |
Latest news on Skyrizi
Complete news archive for SKYRIZI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to SKYRIZI
10 companies that operate in the same segment as SKYRIZI (Gastroenterology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Implantable battery-powered pumps for ascites removal are developed. | 2006 | Zurich, Switzerland | USD 35.5 M | – | – | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | – | 533 | |
Developer of electrosurgical system and range of flexible endoscopic instruments | 2003 | Chepstow, Monmouthshire, United Kingdom | USD 20.84 M | USD 8.08 M | 141 | |
Non-invasive biomarker tests for colorectal cancer are developed. | 2015 | St. Louis, Missouri, United States | USD 218.95 M | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases | 2009 | Ramat Gan, Tel Aviv District, Israel | USD 13.5 M | USD 288.27 K | 35 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SKYRIZI
SKYRIZI was founded in 2018.
SKYRIZI is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
AbbVie is a biopharmaceutical company that researches, develops, and markets treatments for conditions like plaque psoriasis, psoriatic arthritis, Crohns disease, and ulcerative colitis. It operates globally, with headquarters in North Chicago, Illinois, focusing on innovative biologic medications. The company serves healthcare professionals and patients through clinical trials and distribution networks, emphasizing safety and efficacy in immunology therapies.
SKYRIZI's top competitors include Mediately, Iodine and Alibaba Health.
SKYRIZI offers SKYRIZI.
SKYRIZI operates through Abbvie Inc..